as informed in philly
Preserving fertility after breast cancer
Preserving fertility after breast cancerIn 2014, three months after her wedding, Janet Doherty was diagnosed with breast cancer -- invasive ductal carcinoma.During her first visit with her medical oncologist, plans for chemotherapy, radiation, and surgery were mapped out.Overwhelmed, Doherty recalls only bits of that visit, but she does recall is a suggestion that came at the end of the visit,: "You will also need to see one of the fertility specialists immediately if you want to consider pregnancy in the future."The combination of chemotherapy, radiation, and hormonal suppression that was part of her regimen could ultimately impact her ability to conceive naturally.
in like manner wric
Join the fight against breast cancer at the 15th Annual Making Strides of Richmond
Join the fight against breast cancer at the 15th Annual Making Strides of RichmondRICHMOND, Va. (WRIC) — In just a few days, more than 10,000 of your friends and neighbors will gather to make strides against breast cancer.Patti Jackson with the American Cancer Society spoke with 8News anchor Morgan Dean about the event.Making Strides Against Breast Cancer, sponsored by the American Cancer Society, is a non-competitive 5K walk to raise awareness and funds for life-saving breast cancer research and free patient services for breast cancer patients.The idea of the event is to celebrate breast cancer survivors and remember those we have lost to this disease.
by the same token on delawareonline
Funding improves breast cancer survival rates
Funding improves breast cancer survival ratesSkip Ad Ad Loading... x Embed x Share Lois Wilkinson with the Delaware Breast Cancer Coalition talks about raising money to fight breast cancer.Jason Minto/The News JournalBuy Photo April Kloxin, assistant professor of chemical and biomolecular engineering at the University of Delaware, won a $450,000 grant from Susan G. Komen for her work on breast cancer metastasis.(Photo: SUCHAT PEDERSON/THE NEWS JOURNAL)Buy PhotoApril Kloxin is part of an ever-growing body of researchers and clinicians making it their mission to outsmart breast cancer cells.Kloxin, a University of Delaware engineering professor and Pew Scholar in Biomedical Science, wants to know why 20 percent of women who are treated and declared breast cancer-free by their doctors develop breast cancer five to 25 years later.
No comments:
Post a Comment